Vyne Share Price Forecast
Yet prior to the latest estimates, the analysts had been forecasting revenues of us$34m and losses of us$1.37 per share in 2021. This is a 30.77 percent increase over losses of $(0.52) per share
Losses are predicted to fall substantially, shrinking 76% to us$1.36.
Vyne share price forecast. That looks pretty grim, at a glance. Earnings for vyne therapeutics are expected to grow in the coming year, from ($1.34) to ($0.68) per share. In fact, it fell 0.6%.
2021 revenue forecast fell from us$34.0m to us$18.2m. Clicking on names of the stocks will bring you to the price forecasts, while choosing the stock market will list the available stocks on the market. This suggests a possible upside of 441.7% from the stock's current price.
Vyne | complete vyne therapeutics inc. On average, they expect vyne therapeutics' stock price to reach $6.50 in the next year. Shares in vyne therapeutics inc are currently priced at $1.36.
The falls have accelerated recently, with the share price down 47% in the last three months. Consensus price target down from us$11.43 to us$7.86. Vyne therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is thursday, march 3rd, 2022 based off prior year's report dates.
Annual revenue (last year) $21.0m: Vyne therapeutics' revenue didn't grow at all in the last year. Their forecasts range from $6.00 to $7.00.
Pharmaceuticals industry in the us expected to see average net income growth of 14% next year. Price and volume over 1y period. (vyne) has a beta value of 0.70, and an average true range (atr) of 0.09.
Nasdaq updated dec 4, 2021 12:36 am. Nasdaqgs:vyne earnings and revenue growth august 13th 2021 the consensus price target fell 21% to us$9.00, with the analysts clearly concerned about the weaker revenue outlook and expectation of. The share price is down a hefty 63% in that time.
At that level they are trading at 0.265% discount to the analyst consensus target price of 0.00. View as data table, vyne therapeutics inc. The consensus outlook for 2021 has been updated.
Chart represents vyne therapeutics inc. During the day the stock fluctuated 9.18% from a day low at $0.98 to a day high of $1.07. Because vyne therapeutics made a loss in the.
Earnings per share usd dividends usd payout ratio percentage shares mil book value per share usd operating cash flow usd mil cap spending usd mil free cash flow usd mil; Is there a vyne therapeutics inc share price forecast 2021? Check out our latest analysis for vyne therapeutics.
— stock price and discussion | stocktwits. Volume fell on the last day along with the. Vyne therapeutics (nasdaq:vyne) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.32) by 12.5 percent.
Lowering target price to $18.00vanda pharmaceuticals inc has an investment rating of hold; This page offers a collection of popular stock exchanges and their most prominent stocks for which our website offers price predictions. The chart has 1 x axis displaying time.
Get our premium forecast now, from only $8.49! And has now fallen 9 days in a row. (vyne) estimates and forecasts statistics show that vyne therapeutics inc.
Stock was originally listed at a price of $114.84 in jan 25, 2018. A target price of $18.000000; We wouldn't rush to judgement on vyne therapeutics because we don't have a long term history to look at.
Has outperformed its competitors in share price, compared to the industry in which it operates.
Post a Comment for "Vyne Share Price Forecast"